Evidence map›Paper›PMID 36138880›Full record

ArticleBrain sciences2022

RMTF-Net: Residual Mix Transformer Fusion Net for 2D Brain Tumor Segmentation.

Di Gai, Jiqian Zhang, Yusong Xiao, Weidong Min, Yunfei Zhong, Yuling Zhong

Abstract read
In one paragraph

Article in Brain sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Transformers for Neuroimage Segmentation: Scoping Review.Journal of medical Internet research · 2025
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Di GaiSchool of Software, Nanchang University, Nanchang 330047, China.
Jiqian ZhangSchool of Software, Nanchang University, Nanchang 330047, China.
Yusong XiaoSchool of Software, Nanchang University, Nanchang 330047, China.
Weidong MinInstitute of Metaverse, Nanchang University, Nanchang 330031, China.ORCID 0000-0003-2526-2181
Yunfei ZhongSchool of Mathematics and Computer Science, Nanchang University, Nanchang 330031, China.
Yuling ZhongSchool of Software, Nanchang University, Nanchang 330047, China.

Funding

Jiangxi Key Laboratory of Smart City 20192BCD40002National Natural Science Foundation of China 62076117National Natural Science Foundation of China 62166026
6 · The paper itself

Abstract

Due to the complexity of medical imaging techniques and the high heterogeneity of glioma surfaces, image segmentation of human gliomas is one of the most challenging tasks in medical image analysis. Current methods based on convolutional neural networks concentrate on feature extraction while ignoring the correlation between local and global. In this paper, we propose a residual mix transformer fusion net, namely RMTF-Net, for brain tumor segmentation. In the feature encoder, a residual mix transformer encoder including a mix transformer and a residual convolutional neural network (RCNN) is proposed. The mix transformer gives an overlapping patch embedding mechanism to cope with the loss of patch boundary information. Moreover, a parallel fusion strategy based on RCNN is utilized to obtain local-global balanced information. In the feature decoder, a global feature integration (GFI) module is applied, which can enrich the context with the global attention feature. Extensive experiments on brain tumor segmentation from LGG, BraTS2019 and BraTS2020 demonstrated that our proposed RMTF-Net is superior to existing state-of-art methods in subjective visual performance and objective evaluation.

Indexed as

brain tumor segmentationconvolutional neural networkmix transformeroverlapping patch embedding mechanism

Identifiers

PMID36138880
PMCPMC9497369

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.